Biotech 2050 Podcast
40. Approaches to immunology, inflammation, and oncology, Dr. Luisa Salter-Cid, CSO, Gossamer Bio
over 4 years ago
38. AI-driven early detection cancer screening from a blood test, Ken Chahine, CEO, Helio Health
over 4 years ago
37. Bringing new treatments to psychiatric orphan diseases, Ibs Mahmood, CEO, AMO Pharma
over 4 years ago
36. Harnessing the innate immune system to combat disease, RJ Tesi, CEO and CMO, INmune Bio
over 4 years ago
35. Continuous manufacturing in drug development, Matthew Bio, CEO, Snapdragon Chemistry
over 4 years ago
34. Automation and Regenerative Manufacturing, Alexander Titus, Chief Strategy Officer, ARMI
almost 4 years ago